What is the management for a patient with Group B Streptococcus (GBS) in their urine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Group B Streptococcus in Urine

Women with GBS isolated from the urine in any concentration during pregnancy should receive intrapartum antibiotic prophylaxis because they are heavily colonized with GBS and at increased risk of delivering an infant with early-onset GBS disease. 1

Diagnosis and Initial Management

  • GBS bacteriuria during pregnancy is a marker for heavy genital tract colonization and increases the risk for early-onset neonatal GBS disease 1
  • Laboratories should report GBS in urine culture specimens when present at concentrations of ≥10^4 colony-forming units/ml in pure culture or mixed with a second microorganism 1, 2
  • Women with symptomatic or asymptomatic GBS urinary tract infection detected during pregnancy should be treated according to current standards of care for urinary tract infection during pregnancy 1
  • Prenatal culture-based screening at 35-37 weeks' gestation is not necessary for women with GBS bacteriuria, as they are presumed to be GBS colonized 1, 3

Intrapartum Management

  • All women with GBS bacteriuria during the current pregnancy should receive intrapartum antibiotic prophylaxis regardless of the concentration of bacteria found in the urine 1, 4
  • For intrapartum prophylaxis in women without penicillin allergy, the recommended regimen is: penicillin G, 5 million units IV initial dose, then 2.5 million units IV every 4 hours until delivery 1
  • An alternative regimen is ampicillin, 2 g IV initial dose, then 1 g IV every 4 hours until delivery 1

Management for Penicillin-Allergic Patients

  • For women with penicillin allergy who are not at high risk for anaphylaxis: cefazolin, 2 g IV initial dose, then 1 g IV every 8 hours until delivery 1
  • For women at high risk for anaphylaxis (history of anaphylaxis, angioedema, respiratory distress, or urticaria following penicillin or cephalosporin administration):
    • Susceptibility testing for clindamycin and erythromycin should be performed on GBS isolates 1
    • If the isolate is susceptible to clindamycin: clindamycin, 900 mg IV every 8 hours until delivery 1
    • If the isolate is resistant to clindamycin or susceptibility is unknown: consult infectious disease specialist for alternative regimens 1

Special Considerations

  • Women with planned cesarean delivery performed before rupture of membranes and onset of labor are at low risk for having an infant with early-onset GBS disease and should not routinely receive intrapartum chemoprophylaxis for GBS disease prevention, regardless of GBS colonization status 1
  • Women who have previously given birth to an infant with invasive GBS disease should receive intrapartum chemoprophylaxis regardless of current GBS colonization status 1
  • Women with GBS bacteriuria should not be re-screened by genital tract culture or urinary culture in the third trimester, as they are presumed to be GBS colonized 3

Potential Pitfalls and Caveats

  • Failure to report GBS in urine specimens from pregnant women can lead to missed opportunities for intrapartum prophylaxis 1, 2
  • Urine specimens from pregnant patients should be clearly labeled to indicate pregnancy status to assist laboratory processing and appropriate reporting of results 1
  • Antibiotics given before the intrapartum period do not eliminate GBS from the genitourinary and gastrointestinal tracts, and recolonization after a course of antibiotics is typical 1
  • While treating GBS bacteriuria during pregnancy is important, it does not eliminate the need for intrapartum antibiotic prophylaxis 1, 3

Non-Pregnant Adults with GBS Bacteriuria

  • In non-pregnant adults, GBS bacteriuria may signal underlying urinary tract abnormalities (60%) or chronic renal failure (27%) 5
  • Screening for urinary tract abnormalities should be considered in non-pregnant adults with GBS bacteriuria 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Group B Streptococcus in Urine Culture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of group B streptococcal bacteriuria in pregnancy.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2012

Research

Group B Streptococcus: a cause of urinary tract infection in nonpregnant adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.